This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Therapeutic Implications

Ralph R. Weichselbaum, MD; Christopher M. Rose, MD; Thomas J. Ervin, MD; Daniel Miller, MD

Arch Otolaryngol. 1983;109(12):792-796.

Abstract
• Hypoxic cell sensitizers, particle therapy, hyperthermia, and combinations of chemotherapy and radiotherapy have potential to increase the therapeutic ratio in future clinical radiotherapy treatment regimens. The biologic bases of these investigations are beginning to appear as avenues of clinical investigation.

(Arch Otolaryngol 1983;109:792-796)

Author Affiliations
From the Joint Center for Radiation Therapy, Harvard Medical School (Drs Weichselbaum and Rose), and the Division of Medicine, Dana-Farber Cancer Institute (Drs Ervin and Miller), Boston.

Footnotes
Accepted for publication May 3, 1983.

Read before the American Society for Head and Neck Surgery, Palm Springs, Calif, March 11, 1983.

Reprints not available.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?